Algeria Vaccine Industry Outlook 2024 - 2028

See how Algeria Vaccine performed compared to key markets.

Key Market Indicators

**Algerian Vaccination Coverage Set to Remain Steady at 91% by 2028** Algerian vaccination coverage for children aged one year old is projected to maintain a stable rate of 91% by 2028, the same level it is at in 2023. This represents no significant change in the compound annual growth rate (CAGR) over the five-year period. Since 1986, Algeria has consistently maintained a vaccination coverage rate of 91% for this age group, showing no variation year on year. **Vaccine Import Growth** In contrast to the stable vaccination coverage, Algeria's vaccine imports are expected to see significant growth. The value of vaccine imports is anticipated to reach approximately $127 million by 2028, up from around $105 million in 2023. This marks an average annual growth rate of 2.9%. Since 1997, Algeria's demand for vaccines has risen by an average of 5.2% each year. This increasing demand underscores the country's ongoing efforts to bolster its immunization programs despite the stable coverage rates. **Conclusion** While Algeria's vaccination coverage for one-year-olds remains consistently high at 91%, the country is experiencing a notable increase in vaccine imports. This dual trend highlights Algeria's commitment to maintaining robust immunization levels and addressing growing healthcare needs.

Algeria Vaccine Market Data and Forecasts

How much will Algeria Vaccine Market grow to 2028?

Forecast: Import of Vaccines for Human Use to Algeria
Forecast: Import of Vaccines for Human Use to Algeria
Forecast: Baccille Calmette Guérin Vaccine (BCG) Immunization Coverage in Algeria
Forecast: Baccille Calmette Guérin Vaccine (BCG) Immunization Coverage in Algeria

Other Top Countries about Vaccine